21 Aug 20240.1199 +0.0024 +2.04% 0.1199 0.1199 0.1172 259,518 20 Aug 2024 0.1175 -0.0015* -1.26% 0.1158 0.1195 0.1130 339,905 19 Aug 20240.1190 +0.0012 +1.02% 0.116* 0.1190 0.1160 199,908 16 Aug 20240.1178 +0.0032 +2.79% 0.1152 0.1178 0.1101 719,341
JULY 29TH Press Release:
We are confident that thus far our submissions have provided 90-95% percent of the information they require and that Vivos will be able to resubmit the refined IDE application with high quality responses demonstrating a compelling risk/benefit analysis to the FDA within the next 45 days
Dr. Korenko did state on the 29th of July WITHIN 45 days. We're now 24 days in. No ones hyping. Buy.....don't buy.....sell.....don't sell.....doesn't matter to me.....They can pay for them now. Or pay a LOT MORE for them later.....
3:28 PM · Aug 16, 2024
Update from the CEO regarding the ongoing discussions with the FDA. General updates will be posted on this platform as new information becomes available. Subscribe to our newsletter at https://t.co/FfgSTxpyrZ for important press releases for #RadioGel and #IsoPet$RDGLpic.twitter.com/1t2fJ1hcnS